Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig

Anne Folta, Irving G. Joshua, R. Clinton Webb

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Endothelin has been characterized as a potent constricting factor. The purpose of this study was to investigate possible dilator effects of this peptide and to examine whether dilator responses occur through an endothelium-mediated mechanism in guinea pig coronary resistance vessels and isolated aortic rings. Changes in perfusion pressure after bolus injections of endothelin were measured using a constant-flow modified Langendorff preparation with a transducer between the flow pump and the heart. An immediate fall in perfusion pressure, averaging 6 mmHg, was observed after injection of endothelin (10-14-10-12 moles). This effect was maximal at 1 minute and tended to return toward baseline levels within 4 minutes. In response to endothelin (10-9 M), isolated aortic rings relaxed 35% after being contracted with prostaglandin F (10-7 M). In both preparations, dilation was converted to constriction after endothelium damage by oxygen radicals or endothelium removal (mechanical rubbing). Dilator responses to endothelin were blocked by pretreatment for 30 minutes with indomethacin (14 μM) in the presence of an intact endothelium in coronary resistance vessels, whereas in the abdominal aorta they were not. We conclude that endothelin has significant dilator properties and that this effect is opposed by its constrictor action at higher doses. In addition, dilator responses to endothelin require an intact endothelium in both coronary vessels and abdominal aorta. Finally, endothelin-induced dilation in coronary resistance vessels appears to occur through a cyclooxygenase product-mediated mechanism.

Original languageEnglish (US)
Pages (from-to)2627-2635
Number of pages9
JournalLife sciences
Volume45
Issue number26
DOIs
StatePublished - 1989

Fingerprint

Endothelins
Abdominal Aorta
Coronary Vessels
Guinea Pigs
Endothelium
Dilatation
Perfusion
Pressure
Injections
Dinoprost
Prostaglandin-Endoperoxide Synthases
Transducers
Constriction
Indomethacin
Reactive Oxygen Species
Pumps
Peptides

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig. / Folta, Anne; Joshua, Irving G.; Clinton Webb, R.

In: Life sciences, Vol. 45, No. 26, 1989, p. 2627-2635.

Research output: Contribution to journalArticle

@article{452b0963a0e0495d9485ae0bf53d200c,
title = "Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig",
abstract = "Endothelin has been characterized as a potent constricting factor. The purpose of this study was to investigate possible dilator effects of this peptide and to examine whether dilator responses occur through an endothelium-mediated mechanism in guinea pig coronary resistance vessels and isolated aortic rings. Changes in perfusion pressure after bolus injections of endothelin were measured using a constant-flow modified Langendorff preparation with a transducer between the flow pump and the heart. An immediate fall in perfusion pressure, averaging 6 mmHg, was observed after injection of endothelin (10-14-10-12 moles). This effect was maximal at 1 minute and tended to return toward baseline levels within 4 minutes. In response to endothelin (10-9 M), isolated aortic rings relaxed 35{\%} after being contracted with prostaglandin F2α (10-7 M). In both preparations, dilation was converted to constriction after endothelium damage by oxygen radicals or endothelium removal (mechanical rubbing). Dilator responses to endothelin were blocked by pretreatment for 30 minutes with indomethacin (14 μM) in the presence of an intact endothelium in coronary resistance vessels, whereas in the abdominal aorta they were not. We conclude that endothelin has significant dilator properties and that this effect is opposed by its constrictor action at higher doses. In addition, dilator responses to endothelin require an intact endothelium in both coronary vessels and abdominal aorta. Finally, endothelin-induced dilation in coronary resistance vessels appears to occur through a cyclooxygenase product-mediated mechanism.",
author = "Anne Folta and Joshua, {Irving G.} and {Clinton Webb}, R.",
year = "1989",
doi = "10.1016/0024-3205(89)90248-8",
language = "English (US)",
volume = "45",
pages = "2627--2635",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "26",

}

TY - JOUR

T1 - Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig

AU - Folta, Anne

AU - Joshua, Irving G.

AU - Clinton Webb, R.

PY - 1989

Y1 - 1989

N2 - Endothelin has been characterized as a potent constricting factor. The purpose of this study was to investigate possible dilator effects of this peptide and to examine whether dilator responses occur through an endothelium-mediated mechanism in guinea pig coronary resistance vessels and isolated aortic rings. Changes in perfusion pressure after bolus injections of endothelin were measured using a constant-flow modified Langendorff preparation with a transducer between the flow pump and the heart. An immediate fall in perfusion pressure, averaging 6 mmHg, was observed after injection of endothelin (10-14-10-12 moles). This effect was maximal at 1 minute and tended to return toward baseline levels within 4 minutes. In response to endothelin (10-9 M), isolated aortic rings relaxed 35% after being contracted with prostaglandin F2α (10-7 M). In both preparations, dilation was converted to constriction after endothelium damage by oxygen radicals or endothelium removal (mechanical rubbing). Dilator responses to endothelin were blocked by pretreatment for 30 minutes with indomethacin (14 μM) in the presence of an intact endothelium in coronary resistance vessels, whereas in the abdominal aorta they were not. We conclude that endothelin has significant dilator properties and that this effect is opposed by its constrictor action at higher doses. In addition, dilator responses to endothelin require an intact endothelium in both coronary vessels and abdominal aorta. Finally, endothelin-induced dilation in coronary resistance vessels appears to occur through a cyclooxygenase product-mediated mechanism.

AB - Endothelin has been characterized as a potent constricting factor. The purpose of this study was to investigate possible dilator effects of this peptide and to examine whether dilator responses occur through an endothelium-mediated mechanism in guinea pig coronary resistance vessels and isolated aortic rings. Changes in perfusion pressure after bolus injections of endothelin were measured using a constant-flow modified Langendorff preparation with a transducer between the flow pump and the heart. An immediate fall in perfusion pressure, averaging 6 mmHg, was observed after injection of endothelin (10-14-10-12 moles). This effect was maximal at 1 minute and tended to return toward baseline levels within 4 minutes. In response to endothelin (10-9 M), isolated aortic rings relaxed 35% after being contracted with prostaglandin F2α (10-7 M). In both preparations, dilation was converted to constriction after endothelium damage by oxygen radicals or endothelium removal (mechanical rubbing). Dilator responses to endothelin were blocked by pretreatment for 30 minutes with indomethacin (14 μM) in the presence of an intact endothelium in coronary resistance vessels, whereas in the abdominal aorta they were not. We conclude that endothelin has significant dilator properties and that this effect is opposed by its constrictor action at higher doses. In addition, dilator responses to endothelin require an intact endothelium in both coronary vessels and abdominal aorta. Finally, endothelin-induced dilation in coronary resistance vessels appears to occur through a cyclooxygenase product-mediated mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0024829775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024829775&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(89)90248-8

DO - 10.1016/0024-3205(89)90248-8

M3 - Article

C2 - 2693868

AN - SCOPUS:0024829775

VL - 45

SP - 2627

EP - 2635

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 26

ER -